Astro-Med, Inc. (ALOT) - 10-K Summary
Business Context and Reporting Period
Company: Astro-Med, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: January 31, 2008
Business Overview: Astro-Med designs, develops, manufactures, and distributes specialty printers and electronic instruments for data acquisition, processing, and analysis. Operations are organized into three segments: Test & Measurement (T&M), QuickLabel Systems (label printing), and Grass Technologies (GT, neurological instrumentation). The company serves aerospace, automotive, medical, and general manufacturing markets globally, with approximately 30% of sales derived from international customers.
Key Financial Metrics
| Metric (in thousands) | Fiscal 2008 | Fiscal 2007 |
|---|---|---|
| Net Sales | $72,371 | $65,519 |
| Gross Profit | $31,111 | $26,998 |
| Gross Margin | 43.0% | 41.2% |
| Operating Income | $4,199 | $8,742 |
| Net Income | $4,310 | $6,059 |
| Diluted EPS | $0.57 | $0.82 |
| Operating Cash Flow | $2,712 | $2,383 |
| Total Assets | $61,699 | $58,001 |
| Working Capital | $39,411 | $34,294 |
| Long-Term Debt | $0 | $0 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 10.5% to $72.4 million, driven by a 22.6% surge in QuickLabel sales and a 5.2% increase in T&M sales. Grass Technologies sales declined 5.2% due to lower demand for sleep systems and research products.
- Profitability Decline: Despite higher revenue and improved gross margins (43.0% vs. 41.2%), Net Income decreased 29% to $4.3 million. This was primarily due to a $5.25 million one-time gain on the sale of real estate in fiscal 2007, which was absent in 2008.
- Operating Expenses: Operating expenses rose 14.5% to $26.9 million. Increases included higher SG&A costs (personnel, commissions, legal fees) and a $515,000 restructuring charge for closing sales centers in Italy and the Netherlands.
- Segment Performance: QuickLabel operating profit jumped from $1.2 million to $4.2 million. T&M profit improved to $3.1 million. GT profit fell to $1.6 million from $3.1 million.
Outlook, Risks, and Unusual Items
- Restructuring: The company incurred $515,000 in charges related to the closure of European sales centers. A tax benefit of $728,000 was recorded related to this restructuring.
- Investment Risk (Auction Rate Securities): As of January 31, 2008, the company held $6.25 million in auction rate securities. The filing notes that auctions for some of these securities failed subsequent to the balance sheet date due to global credit market liquidity issues. While no write-down was recorded at year-end, the company acknowledges the risk of potential future write-downs if market conditions deteriorate.
- Dividends and Buybacks: The company increased its quarterly dividend to $0.06 per share in Q1 2009. It also repurchased 55,300 shares in Q4 2008, with authorization remaining for 392,289 additional shares.
- Guidance: Management expects to finance future needs through internal funds and a $3.5 million unsecured line of credit. Strategic focus remains on organic growth via R&D (approx. 6.5% of sales) and acquisitions.
Investor Verification Checklist
- Auction Rate Securities Liquidity: Verify the current status and fair value of the $6.25 million auction rate securities portfolio given the post-balance sheet auction failures mentioned in the filing.
- Grass Technologies Turnaround: Assess the reasons for the 5.2% sales decline and 49% drop in operating profit for the GT segment and management's plan to reverse this trend.
- Real Estate Gain Normalization: Confirm that future earnings comparisons exclude the $5.25 million non-recurring gain from the 2007 property sale to accurately gauge operational performance.
- International Exposure: Review the impact of foreign exchange rates on the 30% of sales generated outside the U.S., particularly given the volatility in European markets.
- Restructuring Completion: Monitor the utilization of the $299,761 remaining restructuring reserve and the timeline for cost savings realization from the European closures.